Grazoprevir (MK-5172) With Peg-Interferon and Ribavirin in Participants With Chronic Genotype 2 or 3 Hepatitis C (MK-5172-012)
Clinical trial NCT01440595 · TERMINATED
Trial details
- NCT number
- NCT01440595
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-28
- Primary completion
- 2012-05-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.